Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Looking for participantsNCT05902988What this trial is testingA Phase I/II Study of VLS-1488 in Subjects With Advanced CancerWho this might be right forAdvanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more Volastra Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06814496What this trial is testingRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsWho this might be right forMelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more University of Arizona 30
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT02759835What this trial is testingLocal Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With OsimertinibWho this might be right forLung AdenocarcinomaLung Neoplasms National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT04538378What this trial is testingOlaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine TumorsWho this might be right forEGFR-Mutated Non-Small-Cell Lung CarcinomaSmall Cell/Neuroendocrine National Cancer Institute (NCI) 4
Large-scale testing (Phase 3)UnknownNCT02125240What this trial is testingIcotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung AdenocarcinomaWho this might be right forEGFR Positive Non-small Cell Lung CancerAdenocarcinoma Betta Pharmaceuticals Co., Ltd. 124
Early research (Phase 1)Active Not RecruitingNCT04606472What this trial is testingSI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 60
Not applicableUnknownNCT05395611What this trial is testingExhaled Breath Particles in Lung CancerWho this might be right forLung CancerNon-small Cell Lung CancerLung Adenocarcinoma+1 more Lund University Hospital 300
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647What this trial is testingTesting the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forLung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)Looking for participantsNCT06682793What this trial is testingEvaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more A2 Biotherapeutics Inc. 240
Not applicableStudy completedNCT03232593What this trial is testingAtezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)Who this might be right forUrothelial CarcinomaCarcinoma, Non-Small Cell LungSmall Cell Lung Carcinoma+2 more Hoffmann-La Roche 1,758
Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Testing effectiveness (Phase 2)Study completedNCT00570401What this trial is testingDasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or GefitinibWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Looking for participantsNCT07376707What this trial is testingTGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid TumorsWho this might be right forCRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more Hefei TG ImmunoPharma Co., Ltd. 194
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT01307267What this trial is testingPF-05082566 As A Single Agent And In Combination With RituximabWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more Pfizer 190
Not applicableActive Not RecruitingNCT05812027What this trial is testingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon Small Cell Lung Cancer+4 more TScan Therapeutics, Inc. 1,150